Hutchison China MediTech Ltd ADR buy melinda
Start price
12.03.18
/
50%
€33.42
Target price
12.09.18
€40.59
Performance (%)
-26.30%
End price
12.09.18
€24.63
Summary
This prediction ended on 12.09.18 with a price of €24.63. The price of Hutchison China MediTech Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 1.961% | 1.961% | -22.388% | -12.605% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
Comments by melinda for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
Pharmazeutische SecteurProduits Agenda 12/03 | 08.00 Uhr veröffentlichte Ergebnisse
Hutchison China Meditech wendet sich an die erste Arzneimittelzulassung in diesem Jahr
(Laufzeit überschritten)